Efficacy of medical therapy in preventing the post-surgical recurrence in crohn's disease;Efficacia della terapia medica nella prevenzione della recidiva post-chirurgica della malattia di Crohn

Annali Italiani di Chirurgia

Volumn 74, Issue 6, 2003, Pages 621-625

  Ardizzone, S ^a   Bollani, S ^a   Manzionna, G ^a   Colombo, E ^a   Maconi, G ^a   Imbesi, V ^a   Porro, G Bianchi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Crohn's disease; Medical therapy; Surgery recurrence

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TUMOR NECROSIS FACTOR ALPHA;

CROHN DISEASE; DRUG ANTAGONISM; HUMAN; RECURRENT DISEASE; REVIEW; SMOKING CESSATION;

6-MERCAPTOPURINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESALAMINE; METHOTREXATE; RECURRENCE; SMOKING CESSATION; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4243139624     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Camma C., Giunta M., Rosselli M., Cottone M.: Mesalamine in the maintenance treatment of Crohn's disease: A meta- analysis adjusted for confounding. Gastroenterol, 113:1465-1473, 1997.
2. Lochs H., Mayer M., Fleig W.E., Mortensen P.B., Bauer P., Genser D. et al.: Prophylaxis ofpostoperative relapse in Crohn's disease with Mesalamine: European Cooperative Cohn's Disease Study VI. Gastroenterol, 118:264-273, 2000.
3. Cottone M., Camma C.: Mesalamine and relapse prevention in Crohn's Disease. Gastroenterol, 119:597, 2000.
4. Steinhart A.H., Ewe K., Griffiths A.M., Modigliani R., Thomsen O.O.: Corticosteroids for maintaining remission of Crohn's disease. Cochrane Database Syst Rev, 2:CD000301, 2000.
5. Hellers G., Cortot A., Jewell D.P., Leijonmarck C.E., Lofberg R., Malchow H. et al.: Oral Budesonide for prevention of postsurgical recurrence in Crohn's Disease. The IOIBD Budesonide Study Group. Gastroenterol, 116:294-300, 1999.
6. Ewe K, Bottger T, Buhr H.J., Ecker K.W., Otto H.F.: Low- dose budesonide treatment for prevention of postoperative recurrence of Crohn's Disease: A multicentre randomised placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol, 11:277-282, 1999.
7. Papi C., Lucchetti R., Gili L., Montanti S., Koch M., Capurso L.: Budesonide in the treatment of Crohn's disease: A meta-analysis. Aliment Pharmacol Ther, 14:1419-1428, 2000.
8. Pearson D.C., May G.R., Fick G, Sutherland L.R.: Azathioprine for maintaining remission of Crohn's disease. Mcleod RS Cochrane Database Syst Rev, 2:CD000067, 2000.
9. D'Haens G., Geboes K., Rutgeerts P.: Endoscopic and histologic healing of Crohn's ileo-colitis with azathioprine. Gastrointest endosc, 50:667-671, 1999.
10. Korelitz B., Hanauer S., Rutgeers P., Present D., Peppercorn M.: Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2year multicenter trial. Gastroenterol, 114:A4141, 1998.
11. Boulton-Jones J.R., Pritchard K., Mahmoud A.A.: The use of 6mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Aliment Pharmacol Ther, 14:1561-1565, 2000.
12. Feagan B.G., Fedorak R.N., Irvine E.J., Wild G, Sutherland L., Steinhart A.H. et al.: A comparison of methotrexate with placebo for the maintenance of remission of Crohn's disease. N Engl J Med, 342:1627-1632, 2000.
13. Blam M.E., Stein R.B., Lichtenstein G.R.: Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives. Am J Gastroenterol, 96:1977-97, 2001.
14. Sands B.E.: Novel therapies for inflammatory bowel disease. Gastroenterol Clin North Am, 28:323-51, 1999.
15. Targan S.R., Hanauer S.B., van Deventer S.J.H., Mayer L, Present D.H., Braakman T. et al.: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. N Engl J Med, 337:1029-35, 1997.
16. Rutgeerts P., D'Haens G, Targan S, Vasiliauskas E., Hanauer S.B., Present D.H. et al.: Efficacy and safety or retreatment with antitumor necrosis factor antibody (Infliximab) to maintain remission in Crohn's disease. Gastroenterol, 117:761-9, 1999.
17. D'Haens G., van Deventer S., van Hogezand R : Endoscopic and histological healing with infliximab anti-tumor necrosis factor anti- bodies in Crohn's disease: A European multicenter trial. Gastroenterol, 116:1029-34, 1999.
18. Present D.H., Rutgeerts P., Targan S., Hanauer S.B., Mayer L, van Hogezand R.A. et al.: Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med, 340:1398-405, 1999.
19. Arnott I.D.R., Mcdonald D, Williams A., Ghosh S.: Clinical use of inliximab in Crohn's disease: the Edinburgh experience. Aliment Pharmacol Ther, 15:1639-46, 2001.
20. Ardizzone S., Colombo E., Maconi G., Bollani S., Manzionna G. M.C., Petrone Bianchi Porro G.: Infliximab in treatment of Crohn's disease: the Milan experience. Digest Liver Dis, 34:411-8, 2002.
21. Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R. et al.: Controlled trial of metronidazole treatment for prevention of Crohn's disease recurrence after ileal resection. Gastroenterol, 108:1617-1621, 1995.
22. Campieri M., Rizzello F., Venturi A., Poggioli G., Ugolini F.: Helwig Ulf et al Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomised controlled study vs mesalamine. Gastroenterol, 118: A1764, 2000.
23. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M.: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med, 334:1557-1560, 1996.
24. Lorenz-Mayer H., Bauer P., Nicolay C., Schulz B., Purmann J., Fleig W.E. et al.: Omega-3 fatty acid, a low carbohydrate diet for maintenance of remission in Crohn 's disease. Scan J Gastroenterol, 31:778-785, 1996.
25. Belluzzi A., Campieri C, Belloli C., Boschi S., Cottone M., Rizzello F. et al.: A new enteric-coated preparation of omega-3 fatty acid for preventing post-surgical recurrence in Crohn's disease. Gastroenterol, 112:A 930, 1997.
26. Cosnes J., Carbonnel F., Carrat F., Beaugerie L., Gendre J.P.: Respective effect of current and former cigarette smoking on the clinical course of Crohn's disease. Alim Pharmacol Ther, 13:1403-1411, 1999.
27. Timmer A., Sutherland L.R., Martin F.: Canadian Mesalamine for remission of Crohn's Disease Study Group. Oral contraceptive use and smoking are risk factors for relapse in Crohn s disease. Gastroenterol, 114:1143-1150, 1998.
28. Cosnes J., Beaugerie L, Carbonnel F, Gendre J.P.: Smoking Cessation and course of Crohn's Disease: an intervention study. Gastroenterol, 120:1093-1099, 2001.